Approaches, achievements, challenges, and lessons learned in setting up an urban-based Health and Demographic Surveillance System in South Africa.


Journal

Global health action
ISSN: 1654-9880
Titre abrégé: Glob Health Action
Pays: United States
ID NLM: 101496665

Informations de publication

Date de publication:
01 01 2021
Historique:
entrez: 3 2 2021
pubmed: 4 2 2021
medline: 3 6 2021
Statut: ppublish

Résumé

Reliable civil registration and vital statistics (CRVSs) are essential for estimating mortality rates and population changes, and are critical for public health and socio-economic planning. CRVSs are largely incomplete in Africa, thus Health and Demographic Surveillance Systems (HDSSs) fill gaps in CRVSs, albeit existing HDSSs in South Africa are in rural areas. This limits the generalisability of such data in a country such as South Africa where over 60% live in urban areas, and where there are limitations to access health and social services. We describe the approaches, achievements, challenges and lessons learned in setting up a HDSS site in Soweto and Thembelihle (SaT-HDSS), Johannesburg; which is the first urban-based HDSS in Southern Africa. We also highlight a number of studies being implemented in the HDSS. In 2017-2020, the HDSS has enrolled 124,169 individuals and followed up 95% of this population through 3 rounds of data collection. Several challenges were encountered during the initiation of the HDSS, including difficulties in community mobilisation and entry, stakeholders' engagement and participation, inaccessibility problems and concerns about safety of fieldworkers, and difficulty in getting/recruiting technical staff with requisite experience. Nevertheless, the SaT-HDSS was successfully established through application of several strategies, including continuous community engagement and stakeholders' mobilisation; in-depth training and retraining of all study staff; technical support from well-established HDSS sites across Africa, and international academic collaborations. Despite the challenges of undertaking routine surveillance of a hard-to-reach and highly mobile population, the SaT-HDSS was successfully established with a high-retention rate. The HDSS offers an important lens on morbidity and mortality and serves as a platform for pilots of interventions and programmes aimed at improving health and well-being of an urban population.

Identifiants

pubmed: 33530879
doi: 10.1080/16549716.2021.1874138
pmc: PMC8018403
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1874138

Références

Clin Infect Dis. 2019 Oct 9;69(Suppl 4):S262-S273
pubmed: 31598664
Glob Health Action. 2020 Dec 31;13(1):1811476
pubmed: 32892738
Clin Infect Dis. 2019 Oct 9;69(Suppl 4):S274-S279
pubmed: 31598663
Australas Med J. 2013 Jun 30;6(6):341-3
pubmed: 23837083
Glob Health Action. 2016 Oct 24;9:32795
pubmed: 27782873
Glob Health Action. 2014 May 07;7:23368
pubmed: 24809831

Auteurs

Sunday A Adedini (SA)

Medical Research Council: Vaccine and Infectious Disease Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand , Johannesburg, South Africa.
Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases Unit, Faculty of Health Sciences, University of the Witwatersrand , Johannesburg, South Africa.
Programme in Demography and Population Studies, University of the Witwatersrand, Schools of Public Health and Social Sciences , South Africa.

Dineo Thaele (D)

Medical Research Council: Vaccine and Infectious Disease Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand , Johannesburg, South Africa.
Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases Unit, Faculty of Health Sciences, University of the Witwatersrand , Johannesburg, South Africa.

Matshidiso Sello (M)

Medical Research Council: Vaccine and Infectious Disease Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand , Johannesburg, South Africa.
Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases Unit, Faculty of Health Sciences, University of the Witwatersrand , Johannesburg, South Africa.

Portia Mutevedzi (P)

Medical Research Council: Vaccine and Infectious Disease Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand , Johannesburg, South Africa.
Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases Unit, Faculty of Health Sciences, University of the Witwatersrand , Johannesburg, South Africa.

Cleopas Hywinya (C)

Medical Research Council: Vaccine and Infectious Disease Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand , Johannesburg, South Africa.
Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases Unit, Faculty of Health Sciences, University of the Witwatersrand , Johannesburg, South Africa.

Nonhlanhla Ngwenya (N)

Medical Research Council: Vaccine and Infectious Disease Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand , Johannesburg, South Africa.
Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases Unit, Faculty of Health Sciences, University of the Witwatersrand , Johannesburg, South Africa.

Nellie Myburgh (N)

Medical Research Council: Vaccine and Infectious Disease Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand , Johannesburg, South Africa.
Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases Unit, Faculty of Health Sciences, University of the Witwatersrand , Johannesburg, South Africa.

Shabir A Madhi (SA)

Medical Research Council: Vaccine and Infectious Disease Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand , Johannesburg, South Africa.
Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases Unit, Faculty of Health Sciences, University of the Witwatersrand , Johannesburg, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH